Hepatitis a virus antigen - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
HAVRIX JUNIOR inactivated hepatitis A vaccine 720 ELISA units/0.5mL injection pre-filled syringe with attached needle & without attached needle
AUST R: 147335
Active ingredients:
Hepatitis a virus antigen

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

From
01 Feb 2019
to
30 Jun 2019

Status:
Current

Patient impact:
Medium

Availability:
Limited Availability

Reason:
Manufacturing

TGA Management Actions:
4/1/19 The sponsor is closely controlling the supply

TWINRIX (combined hepatitis A & hepatitis B vaccine) 1 mL injection pre-filled syringe thiomersal & preservative free
AUST R: 140575
Active ingredients:
Hepatitis a virus antigen
Hepatitis B surface antigen recombinant

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

From
15 Feb 2019
to
01 Jul 2019

Status:
Current

Patient impact:
Medium

Availability:
Limited Availability

Reason:
Manufacturing

TGA Management Actions:
18/02/19 The sponsor is closely controlling the supply.

AVAXIM inactivated hepatitis A vaccine 160U/ 0.5mL injection needle free syringe
AUST R: 194815
Active ingredients:
Hepatitis a virus antigen

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

From
22 Jan 2019
to
15 Feb 2019

Status:
Resolved

Patient impact:
Medium

Availability:
Available

Reason:
Unexpected Increase in Demand

TWINRIX JUNIOR (combined hepatitis A & hepatitis B vaccine) 0.5 mL injection pre-filled syringe thiomersal & preservative free
AUST R: 140576
Active ingredients:
Hepatitis a virus antigen
Hepatitis B surface antigen recombinant

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

From
31 May 2019
to
01 Jul 2019

Status:
Anticipated

Patient impact:
Medium

Availability:
Available

Reason:
Manufacturing